The India Cements (INDIACEM) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
3 Feb, 2026Executive summary
Achieved sales of over 31 million tons of cement in Q2 FY26, with strong growth in premium and rural markets, and rapid brand conversion of acquired assets.
Domestic sales volume reached 2.44 MnT in Q2 FY26, up 11.9% quarter-over-quarter, with average capacity utilization at 65%.
Standalone and consolidated unaudited financial results for the quarter and half-year ended 30 September 2025 were approved, with continued operational focus on cement and related products.
Brand sales grew 13.2% year-over-year, with rural market growth at 13% and industry rural growth estimated at 10%.
Net cement realizations declined 0.6% quarter-over-quarter; operating EBITDA per metric ton was ₹386, down from ₹400 in Q1 FY26.
Financial highlights
Sales volume growth of 22.3% year-over-year excluding UltraTech and Kesoram, 9.6% excluding UltraTech, and 6.8% including both.
Revenue from operations for Q2 FY26 was ₹1,117 Crores, up from ₹1,007 Crores in Q2 FY25.
Consolidated EBITDA improved to ₹110 Crores from a loss of ₹4 Crores in Q2 FY25.
Standalone revenue from operations for Q2 FY26 was ₹1,117.15 crore, up from ₹1,024.63 crore in Q1 FY26, but net loss for the quarter was ₹6.86 crore, improving from a loss of ₹13.76 crore in Q1.
PAT before exceptions turned positive at ₹15 Crores, compared to a loss of ₹116 Crores in Q2 FY25.
Outlook and guidance
Brand transition for acquired assets to complete by June 2026, with synergy benefits expected to accelerate.
Capex plan of ₹2,000 Crores over the next two years focuses on growth and efficiency improvements.
Expansion to 24–25 million tons by FY29, with further brownfield and greenfield potential beyond 2030.
Green power (RE + WHRS) targeted to scale from 5% to 80% by FY28.
The company is undergoing restructuring, including the amalgamation of four wholly owned subsidiaries, pending regulatory approvals.
Latest events from The India Cements
- Sales up 25% YoY, revenue higher, but net losses persist amid expansion and legal risks.INDIACEM
Q3 25/262 Feb 2026 - Sales volume up to 11.6% YoY, EBITDA/ton improved, losses narrowed, double-digit growth targeted.INDIACEM
Q1 25/266 Jan 2026 - Profitability returned in Q1 FY25 on an exceptional gain, with major stake sale to UltraTech Cement.INDIACEM
Q1 24/251 Sep 2025 - Losses widened on lower revenue, with major asset sales and a pending UltraTech acquisition.INDIACEM
Q2 24/251 Sep 2025 - Q3 FY25 saw lower revenue, major losses, UltraTech's takeover, and large asset revaluation gains.INDIACEM
Q3 24/251 Sep 2025 - FY25 saw deeper losses, lower revenue, and major legal disputes, with auditors' unmodified opinions.INDIACEM
Q4 24/251 Sep 2025